Symptomatic knee osteoarthritis
The evidence is most consistent for mild or moderate knee osteoarthritis when therapeutic exercise, load management and other non-surgical options have not adequately controlled the symptoms.
Non-surgical orthopaedic treatment
An injection is a selective option incorporated into a treatment plan once the diagnosis has been established. PRP is used mainly to help control symptoms in mild or moderate knee osteoarthritis in carefully selected patients.
Clinical principle
PRP—platelet-rich plasma—is obtained from the patient's own blood by separating and concentrating a platelet-rich fraction. It does not contain stem cells and should not be presented as a treatment that reverses osteoarthritis.
The realistic goal is to reduce pain and improve function for a variable period, allowing the patient to continue therapeutic exercise and activities appropriate to their condition.
Selecting the clinical indication
The evidence is most consistent for mild or moderate knee osteoarthritis when therapeutic exercise, load management and other non-surgical options have not adequately controlled the symptoms.
For the hip, shoulder or ankle, the evidence is less consistent. The precise location of the pain, the diagnosis and the quality of evidence for the particular condition should be discussed before the procedure.
A swollen joint or a large effusion may require clarification of the cause and, sometimes, joint aspiration or tests before an injectable product is selected. Infection must be excluded when the clinical picture raises suspicion.
The procedure
The protocol is tailored to the joint, the stage of the condition, previous treatments and the patient's medical profile.
Symptoms, clinical examination findings and investigations are assessed together to confirm the source of the pain and the severity of joint damage.
A sample of venous blood is collected under sterile conditions, much like a routine blood draw.
The blood is centrifuged to separate the plasma fraction that will be used. PRP products prepared by different systems do not all have the same composition.
The product is injected into the joint, with imaging guidance when the anatomy or the joint makes this necessary. Aftercare advice and reassessment are individualised.
Choosing the product
PRP is an autologous product derived from the patient's own blood. In mild or moderate knee osteoarthritis, it may reduce pain and improve function in selected patients, although the magnitude and duration of benefit vary.
A corticosteroid may provide short-term relief in certain situations. Guideline recommendations differ for hyaluronic acid. These products are not equivalent and should not be repeated automatically without reassessment.
Safety
Tell your doctor if you have a fever, an active infection, a skin lesion near the injection site or a blood disorder, or if you take anticoagulant or antiplatelet medication. Do not stop any treatment on your own initiative.
A temporary painful or inflammatory reaction may occur after the injection. Fever, spreading redness, marked local warmth, pronounced swelling or persistent worsening of pain requires prompt medical assessment.
Further information
PRP should not be presented as a method that is guaranteed to rebuild cartilage. In selected patients, it may reduce symptoms and improve function, but the response varies and the osteoarthritis does not disappear.
The evidence is most consistent for mild or moderate symptomatic knee osteoarthritis. PRP is considered after the diagnosis has been confirmed and previous non-surgical treatments have been reviewed.
There is no single protocol suitable for everyone. The number of injections and the interval between them depend on the product used, the confirmed diagnosis, the severity of the condition and the clinical response.
When an effect occurs, it is usually gradual. Pain may temporarily increase after the procedure, and the outcome cannot be guaranteed or properly assessed after only a few days.
PRP has also been studied in other joints, but the evidence is less consistent than for knee osteoarthritis. An indication established for the knee should not be automatically extended to every painful joint.
Appointment
The consultation determines whether an injection has a realistic goal, which option may be considered and how it fits into a complete rehabilitation and follow-up plan.
In an acute or life-threatening situation, call 112 or go to the nearest emergency department.